Market Expansion Potential Resolution Biomedical has actively expanded into developing world markets such as South America, Eastern Europe, and Southeast Asia, indicating opportunities to partner with healthcare providers and laboratories looking for affordable, high-quality cytology solutions tailored to emerging markets.

Innovative Technology Focus The company's proprietary ClearPrep liquid-based cytology technology, which offers superior results and multiple reflex tests from a single sample, positions it as a valuable partner for laboratories seeking innovative, cost-effective diagnostic solutions.

Product & Service Expansion With ongoing development in areas like fine needle aspirates, bladder cancer screening, and oral cancer detection, there is a potential to sell complementary testing kits and automation equipment to laboratories aiming to broaden their diagnostic offerings.

Competitive Niche As a smaller player in a market dominated by large firms, Resolution Biomedical can leverage its focus on affordability and innovation to target mid-sized labs and clinics seeking high-quality cytology methods at competitive prices.

Regional Growth Opportunities Given the company's recent expansion focus, exploring partnerships and distribution channels in targeted regions could accelerate sales growth by tapping into increasing demand for accessible cancer screening and STD testing services.